Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on May 21, 2026

May 21, 2026

Petmetrics & Linear Dimensions Announce Collaboration to Develop Advanced Pet Diagnostic Wearables

Indeterminate EIN Presswire

May 21, 2026

Global Medical Response Joins National EMS Quality Alliance as Stakeholder Member

Indeterminate EIN Presswire

May 21, 2026

C3HIE Goes Live with TEFCA Through eHealth Exchange QHIN Connectivity

Indeterminate EIN Presswire

May 21, 2026

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

May 21, 2026

SeniorCRE® Releases Strategic White Paper: The Fragmentation Problem in Senior Living and Care Operations and Capital

Indeterminate EIN Presswire

May 21, 2026

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

Indeterminate GlobeNewswire

May 21, 2026

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease

Indeterminate GlobeNewswire

May 21, 2026

Perspective Therapeutics to Present Data from All Clinical Programs at the 2026 ASCO Annual Meeting, including Findings from [212Pb]VMT01 in Melanoma

Indeterminate GlobeNewswire

May 21, 2026

Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026

Indeterminate GlobeNewswire

May 21, 2026

Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

Indeterminate GlobeNewswire

May 21, 2026

Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire

May 21, 2026

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors

Indeterminate GlobeNewswire

May 21, 2026

Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering

Indeterminate GlobeNewswire

May 21, 2026

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

Indeterminate GlobeNewswire

May 21, 2026

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026

Indeterminate GlobeNewswire

May 21, 2026

Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical Oncology Annual Meeting 2026

Indeterminate GlobeNewswire

May 21, 2026

Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology

Indeterminate GlobeNewswire

May 21, 2026

Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin

Indeterminate GlobeNewswire

May 21, 2026

Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis

Indeterminate GlobeNewswire

May 21, 2026

Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Indeterminate GlobeNewswire